137 related articles for article (PubMed ID: 28069867)
21. MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance.
Messéant J; Dobbertin A; Girard E; Delers P; Manuel M; Mangione F; Schmitt A; Le Denmat D; Molgó J; Zytnicki D; Schaeffer L; Legay C; Strochlic L
J Neurosci; 2015 Mar; 35(12):4926-41. PubMed ID: 25810523
[TBL] [Abstract][Full Text] [Related]
22. Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
Arimura S; Okada T; Tezuka T; Chiyo T; Kasahara Y; Yoshimura T; Motomura M; Yoshida N; Beeson D; Takeda S; Yamanashi Y
Science; 2014 Sep; 345(6203):1505-8. PubMed ID: 25237101
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase CK2 interacts at the neuromuscular synapse with Rapsyn, Rac1, 14-3-3γ, and Dok-7 proteins and phosphorylates the latter two.
Herrmann D; Straubinger M; Hashemolhosseini S
J Biol Chem; 2015 Sep; 290(37):22370-84. PubMed ID: 26198629
[TBL] [Abstract][Full Text] [Related]
24. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D
PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516
[TBL] [Abstract][Full Text] [Related]
25.
Miyoshi S; Tezuka T; Arimura S; Tomono T; Okada T; Yamanashi Y
EMBO Mol Med; 2017 Jul; 9(7):880-889. PubMed ID: 28490573
[TBL] [Abstract][Full Text] [Related]
26. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor γ coactivator 1α regulates downstream of tyrosine kinase-7 (Dok-7) expression important for neuromuscular junction formation.
Sugimoto T; Sakamaki C; Kimura T; Eguchi T; Miura S; Kamei Y
Sci Rep; 2024 Jan; 14(1):1780. PubMed ID: 38245592
[TBL] [Abstract][Full Text] [Related]
28. [Overview: MuSK/Dok-7].
Motomura M; Fukuda T; Yoshimura T; Tsujihata M
Nihon Rinsho; 2008 Jun; 66(6):1140-8. PubMed ID: 18540360
[TBL] [Abstract][Full Text] [Related]
29. Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase.
Jones N; Hardy WR; Friese MB; Jorgensen C; Smith MJ; Woody NM; Burden SJ; Pawson T
Mol Cell Biol; 2007 Jul; 27(13):4759-73. PubMed ID: 17452444
[TBL] [Abstract][Full Text] [Related]
30. Activation of receptor protein-tyrosine kinases from the cytoplasmic compartment.
Yamanashi Y; Tezuka T; Yokoyama K
J Biochem; 2012 Apr; 151(4):353-9. PubMed ID: 22343747
[TBL] [Abstract][Full Text] [Related]
31. Kinase- and rapsyn-independent activities of the muscle-specific kinase (MuSK).
Bromann PA; Zhou H; Sanes JR
Neuroscience; 2004; 125(2):417-26. PubMed ID: 15062984
[TBL] [Abstract][Full Text] [Related]
32. Developmental consequences of the ColQ/MuSK interactions.
Karmouch J; Dobbertin A; Sigoillot S; Legay C
Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
[TBL] [Abstract][Full Text] [Related]
33. Localization and regulation of MuSK at the neuromuscular junction.
Bowen DC; Park JS; Bodine S; Stark JL; Valenzuela DM; Stitt TN; Yancopoulos GD; Lindsay RM; Glass DJ; DiStefano PS
Dev Biol; 1998 Jul; 199(2):309-19. PubMed ID: 9698449
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
Madhavan R; Zhao XT; Ruegg MA; Peng HB
Mol Cell Neurosci; 2005 Mar; 28(3):403-16. PubMed ID: 15737732
[TBL] [Abstract][Full Text] [Related]
35. From phosphorylation to phenotype - Recent key findings on kinase regulation, downstream signaling and disease surrounding the receptor tyrosine kinase MuSK.
Prömer J; Barresi C; Herbst R
Cell Signal; 2023 Apr; 104():110584. PubMed ID: 36608736
[TBL] [Abstract][Full Text] [Related]
36. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
[TBL] [Abstract][Full Text] [Related]
37. A novel pathway for MuSK to induce key genes in neuromuscular synapse formation.
Lacazette E; Le Calvez S; Gajendran N; Brenner HR
J Cell Biol; 2003 May; 161(4):727-36. PubMed ID: 12756238
[TBL] [Abstract][Full Text] [Related]
38. APC2
Chen A; Bai L; Zhong K; Shu X; Wang A; Xiao Y; Zhang K; Shen C
FASEB J; 2020 Sep; 34(9):12009-12023. PubMed ID: 32687671
[TBL] [Abstract][Full Text] [Related]
39. Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.
Mori S; Yamada S; Kubo S; Chen J; Matsuda S; Shudou M; Maruyama N; Shigemoto K
J Neuroimmunol; 2012 Mar; 244(1-2):1-7. PubMed ID: 22222307
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference.
Kong XC; Barzaghi P; Ruegg MA
EMBO Rep; 2004 Feb; 5(2):183-8. PubMed ID: 14749715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
